BAJAJ BROKING

Notification close image
No new Notification messages
card image
Travel Food Services IPO is Open!
Apply for the Travel Food Services IPO through UPI in just minutes.
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

5248

524412

AAREYDRUGS

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

AAREY DRUGS & PHARM LTD performance

Today’s low

Today’s high

₹ 69.55 ₹ 70.30
₹ 69.55

52 week low

52 week high

₹ 31.35 ₹ 74.80
₹ 69.55

Open Price

₹ 69.55

Prev. Close

₹ 70.97

Volume (Shares)

22738.00

Total traded value

₹ 15.81

Upper Circuit

₹ 72.38

Lower Circuit

₹ 69.55

info

AAREY DRUGS & PHARM LTD Share Price Update

As of the latest trading session, AAREY DRUGS & PHARM LTD share price is currently at ₹ 69.55, which is down by ₹ -1.41 from its previous closing. Today, the stock has fluctuated between ₹ 69.55 and ₹ 70.30. Over the past year, AAREY DRUGS & PHARM LTD has achieved a return of 45.87 %. In the last month alone, the return has been 29.93 %. Read More...

Investment Returns

Over 1 Month 29.93% Over 3 Months 56.73% Over 6 Months 22.08% Over 1 Year 45.87%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

AAREY DRUGS & PHARM LTD fundamentals


  • Market cap (Cr)

    197.20

  • P/E Ratio (TTM)

    49.30

  • Beta

    0.89

  • Book Value / share

    48.94

  • Return on equity

    3.74%

  • EPS (TTM)

    1.42

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    0.47

info icon alternate text
  • Market cap (Cr)

    195.10

  • P/E Ratio (TTM)

    49.30

  • Beta

    0.72

  • Book Value / share

    48.94

  • Return on equity

    3.74%

  • EPS (TTM)

    1.42

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    0.47

info icon alternate text

AAREY DRUGS & PHARM LTD Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars MAR 2025 (Values in Cr)
Revenue 108.10
Operating Expense 114.01
Net Profit 0.47
Net Profit Margin (%) 0.43
Earnings Per Share (EPS) 0.02
EBITDA 2.68
Effective Tax Rate (%) 70.55
Particulars DEC 2024 (Values in Cr)
Revenue 133.79
Operating Expense 133.07
Net Profit 0.72
Net Profit Margin (%) 0.53
Earnings Per Share (EPS) 0.26
EBITDA 2.88
Effective Tax Rate (%) 48.57
Particulars SEP 2024 (Values in Cr)
Revenue 105.14
Operating Expense 103.42
Net Profit 1.60
Net Profit Margin (%) 1.52
Earnings Per Share (EPS) 0.57
EBITDA 3.75
Effective Tax Rate (%) 8.57
Particulars JUN 2024 (Values in Cr)
Revenue 126.91
Operating Expense 127.16
Net Profit 1.24
Net Profit Margin (%) 0.97
Earnings Per Share (EPS) 0.44
EBITDA 2.76
Effective Tax Rate (%) 6.76
Particulars MAR 2024 (Values in Cr)
Revenue 210.35
Operating Expense 213.35
Net Profit 2.15
Net Profit Margin (%) 1.02
Earnings Per Share (EPS) 0.77
EBITDA 3.69
Effective Tax Rate (%) -0.46
Particulars MAR 2025 (Values in Cr)
Revenue 473.94
Operating Expense 477.65
Net Profit 4.02
Net Profit Margin (%) 0.84
Earnings Per Share (EPS) 1.43
EBITDA 12.05
Effective Tax Rate (%) 34.09
Particulars MAR 2024 (Values in Cr)
Revenue 395.62
Operating Expense 397.24
Net Profit 4.68
Net Profit Margin (%) 1.18
Earnings Per Share (EPS) 1.84
EBITDA 11.42
Effective Tax Rate (%) 12.35
Particulars MAR 2023 (Values in Cr)
Revenue 418.96
Operating Expense 415.67
Net Profit 3.78
Net Profit Margin (%) 0.90
Earnings Per Share (EPS) 1.49
EBITDA 10.46
Effective Tax Rate (%) 37.20
Particulars MAR 2022 (Values in Cr)
Revenue 492.68
Operating Expense 485.40
Net Profit 6.54
Net Profit Margin (%) 1.32
Earnings Per Share (EPS) 2.72
EBITDA 14.02
Effective Tax Rate (%) 34.69
Particulars MAR 2021 (Values in Cr)
Revenue 348.42
Operating Expense 347.13
Net Profit 6.51
Net Profit Margin (%) 1.86
Earnings Per Share (EPS) 2.79
EBITDA 11.65
Effective Tax Rate (%) 21.56
Particulars MAR 2024 (Values in Cr)
Book Value / Share 45.57
ROE % 3.74
ROCE % 6.09
Total Debt to Total Equity 0.28
EBITDA Margin 2.89
Particulars MAR 2023 (Values in Cr)
Book Value / Share 44.43
ROE % 3.26
ROCE % 6.28
Total Debt to Total Equity 0.22
EBITDA Margin 2.49
Particulars MAR 2022 (Values in Cr)
Book Value / Share 43.85
ROE % 6.16
ROCE % 9.79
Total Debt to Total Equity 0.15
EBITDA Margin 2.86
Particulars MAR 2021 (Values in Cr)
Book Value / Share 41.29
ROE % 6.81
ROCE % 9.38
Total Debt to Total Equity 0.19
EBITDA Margin 3.35
Particulars MAR 2020 (Values in Cr)
Book Value / Share 38.50
ROE % 6.47
ROCE % 8.48
Total Debt to Total Equity 0.19
EBITDA Margin 3.31
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1.59
Total Assets 303.29
Total Liabilities 303.29
Total Equity 132.77
Share Outstanding 28054303
Price to Book Ratio 0.98
Return on Assets (%) 1.54
Return on Capital (%) 2.85
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.70
Total Assets 291.32
Total Liabilities 291.32
Total Equity 117.40
Share Outstanding 25384684
Price to Book Ratio 0.53
Return on Assets (%) 1.29
Return on Capital (%) 2.43
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.19
Total Assets 245.16
Total Liabilities 245.16
Total Equity 113.63
Share Outstanding 25384684
Price to Book Ratio 0.94
Return on Assets (%) 2.67
Return on Capital (%) 5.13
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.64
Total Assets 233.03
Total Liabilities 233.03
Total Equity 98.86
Share Outstanding 23384684
Price to Book Ratio 0.56
Return on Assets (%) 2.79
Return on Capital (%) 5.57
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.50
Total Assets 194.08
Total Liabilities 194.08
Total Equity 92.34
Share Outstanding 23384684
Price to Book Ratio 0.35
Return on Assets (%) 2.98
Return on Capital (%) 5.26
Particulars MAR 2024 (Values in Cr)
Net Income 5.34
Cash from Operations -1.66
Cash from Investing -1.70
Cash from Financing 5.58
Net change in Cash 0.88
Free Cash Flow -0.94
Particulars MAR 2023 (Values in Cr)
Net Income 6.00
Cash from Operations 0.99
Cash from Investing 0.44
Cash from Financing 1.35
Net change in Cash 0.51
Free Cash Flow 2.04
Particulars MAR 2022 (Values in Cr)
Net Income 10.02
Cash from Operations 4.08
Cash from Investing -3.21
Cash from Financing 2.25
Net change in Cash -0.45
Free Cash Flow 6.29
Particulars MAR 2021 (Values in Cr)
Net Income 8.30
Cash from Operations 7.14
Cash from Investing -2.87
Cash from Financing -2.45
Net change in Cash 0.14
Free Cash Flow 10.02
Particulars MAR 2020 (Values in Cr)
Net Income 7.24
Cash from Operations 4.35
Cash from Investing -0.91
Cash from Financing -1.80
Net change in Cash 0.13
Free Cash Flow 5.27
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.35 27.75 1.99 278.56 34.11 / 77.70
BLISS GVS PHARMA LTD 163.05 20.41 1.63 1719.29 105.05 / 184.95
CIPLA LTD 1510.85 23.71 3.91 122032.54 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 328.25 12.57 2.66 966.07 189.00 / 449.00
GLAXOSMITHKLINE PHARMA LT 3281.65 63.61 28.49 55593.13 1924.30 / 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.35 36.35 5.74 278.56 34.11 / 77.70
AMRUTAJAN HEALTH LTD 715.05 40.67 6.32 2067.25 548.05 / 861.40
ASTRAZENECA PHARMA IND LT 9138.10 130.51 29.65 22845.25 6222.35 / 10653.05
BLISS GVS PHARMA LTD 163.05 24.93 1.62 1719.29 105.05 / 184.95

AAREY DRUGS & PHARM LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
69.55 -2.00 redarrow
red-green-graph indicator
2 Bearish
14 Bullish
  • 5 Days 70.30
  • 26 Days 62.10
  • 10 Days 67.70
  • 50 Days 58.00
  • 12 Days 66.80
  • 100 Days 54.70
  • 20 Days 63.70
  • 200 Days 53.50
71.78 PIVOT

First Support

71.14

First Resistance

73.06

Second Support

69.86

Second Resistance

73.70

Third Support

69.22

Third Resistance

74.98

RSI

76.11

ADX

35.52

MACD

4.64

Williams % R

-7.51

Commodity Channel Index (CCI)

110.38

Date

2025-05-28

Week

23206.00

Same Day

22467.00

Month

48202.00

1 Year

0.90

3 Year

0.63

Over 1 Month

29.93%

down

Over 1 Year

45.87%

down

Over 3 Months

56.73%

down

Over 3 Years

26.87%

down

Over 6 Months

22.08%

down

Over 5 Years

0.00%

down

AAREY DRUGS & PHARM LTD shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
52.86%
Promoter Holdings
44.79%
FII
2.33%
DII
0.0%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Bina Rajesh Ghatalia 4003584.0 (14.12%) Shareholding of Promoter and Promoter Group
Mihir Rajesh Ghatalia 2835888.0 (10.0%) Shareholding of Promoter and Promoter Group
Suraj Tradelinks 2010000.0 (7.09%) Shareholding of Promoter and Promoter Group
Nimit Impex 2010000.0 (7.09%) Shareholding of Promoter and Promoter Group
Nimit Rajesh Ghatalia 1150000.0 (4.06%) Shareholding of Promoter and Promoter Group
Mira Mihir Ghatalia 690000.0 (2.43%) Shareholding of Promoter and Promoter Group
India Opportunities Growth Fund Ltd - Pinewood 663105.0 (2.34%) Public Shareholding
Krishnamurthy C G 490000.0 (1.73%) Public Shareholding
Chetan Kiritbhai Mehta 450000.0 (1.59%) Public Shareholding
Archana Pramod Wani 400000.0 (1.41%) Public Shareholding
Black Hawk Properties Private Limited 380000.0 (1.34%) Public Shareholding
Zil Penil Doshi 375000.0 (1.32%) Public Shareholding
Vijaykumar Babulal Shah 300000.0 (1.06%) Public Shareholding
Rajesh Pranlal Ghatalia 2971.0 (0.01%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

AAREY DRUGS & PHARM LTD corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
13 Dec 2018 0.1 Interim 14 Dec 2018 Equity shares
Ex-Date Ex-Bonus Ratio
26 Jun 2012 25 Jun 2012 1:5
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
13 Dec 2018 0.1 Interim 14 Dec 2018 Equity shares
Ex-Date Ex-Bonus Ratio
26 Jun 2012 25 Jun 2012 1:5
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

AAREY DRUGS & PHARM LTD Share Price

Aarey Drugs & Pharmaceuticals Ltd was originally incorporated on May 15, 1990 as a private limited company in Mumbai with the name Niharika Textiles & Chemicals Pvt Ltd. The company was originally promoted by Prakash Mandhana, Kavita Mandhana and Neeta Mandhana. In March, 1993, the Aarey Group of companies belonging to Ghatalia family took over the company and the company was converted into public limited company. Also, the name of the company was changed from Niharika Textiles & Chemicals Pvt Ltd to Aarey Drugs & Pharmaceuticals Ltd.

The Company is one of the manufacturer and suppliers of pharmaceutical raw materials, Chemicals, Pharmaceuticals ingredients, API's Drugs, Food Colours and Flavours. The company is engaged in the business of manufacturing, selling of drugs & pharmaceutical products and is governed by a number of central and state legislations that regulate the business. Apart from the bulk drug manufacturing activity, they also undertake importing & distributing of various industrial chemicals & solvents throughout the country. The company has their manufacturing unit located at Thane.

The company's products include Methyl Nitro Imidazole, Metronidazole & Metronidazole Benzoate. Their pharmaceutical products are sourced from the authentic vendors to assure the quality and effectiveness. The pharmaceutical products offered by the company are in compliance with IP/ BP/ CP/ USP standards. They have their registered office is located at Thane and their corporate office is located at Mumbai.

The company was established with the main object setting up manufacturing facilities for Bulk Drugs. In the year 1993, the company came with a public issue of 27,50,000 equity shares of Rs 10 each for cash at par aggregating to Rs 275 lakh. Also, the company shares were listed on the BSE, ASE & DSE.

In May 2009, the company plant started to upgrade the existing plant into international standards.

In June 2016, the Company commenced manufacturing of Mono Methyl Urea & Di Methyl Urea. In 2017-18, it added new products i.e. Erithromycin Derivates & Mafenamic Acid with capacity of 10 m.t. & 25 m.t. respectively in June' 2017.

In 2018-19, it commenced manufacturing of products i.e. Ortho Para Nitro Anisole, 2-Bromomethyl-1,3 dioxolane, and Mefenamic Acid. It also commenced manufacturing products i.e.Metformin & Urasil.

Parent organization Indian Private
NSE symbol AAREYDRUGS
Founded 1990
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Aarey Drugs & Pharmaceuticals Ltd?

Answer Field

Aarey Drugs & Pharmaceuticals Ltd share price is for NSE ₹ 69.55 & for BSE ₹ 68.82 as on Jul 08 2025 03:15 PM.

What is the Market Cap of Aarey Drugs & Pharmaceuticals Ltd Share?

Answer Field

The market cap of Aarey Drugs & Pharmaceuticals Ltd for NSE ₹ 197.20 & for BSE ₹ 0.00 as on Jul 08 2025 03:15 PM.

What is the 52 Week High and Low of Aarey Drugs & Pharmaceuticals Ltd?

Answer Field

The 52 Week High and Low of Aarey Drugs & Pharmaceuticals Ltd for NSE is ₹ 74.80 and ₹ 31.35 and for BSE is ₹ 75.75 and ₹ 31.30.

What is 1 year return for Aarey Drugs & Pharmaceuticals Ltd?

Answer Field

The 1 year returns on the stock has been 45.87%.

What is the P/E Ratio of Aarey Drugs & Pharmaceuticals Ltd Share?

Answer Field

As on Jul 08 2025 03:15 PM the price-to-earnings (PE) ratio for Aarey Drugs & Pharmaceuticals Ltd share is 49.30.

What is the PB ratio of Aarey Drugs & Pharmaceuticals Ltd Share?

Answer Field

As on Jul 08 2025 03:15 PM, the price-to-book (PB) ratio for Aarey Drugs & Pharmaceuticals Ltd share is 48.94.

How to Buy Aarey Drugs & Pharmaceuticals Ltd Share?

Answer Field

You can trade in Aarey Drugs & Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Aarey Drugs & Pharmaceuticals Ltd Share on Bajaj Broking App?

Answer Field

To buy Aarey Drugs & Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Aarey Drugs & Pharmaceuticals Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|